NCT04668911 (ORACLE) is a clinical trial of Swab in Covid19, sponsored by Eastman Dental Insitute and Hospital.

Who is sponsoring NCT04668911?

NCT04668911 is sponsored by Eastman Dental Insitute and Hospital.

What drugs are being tested in NCT04668911?

Interventions in NCT04668911: Swab.

What condition does NCT04668911 study?

NCT04668911 studies Covid19, Periodontitis.

Is NCT04668911 still recruiting?

NCT04668911 is currently status unknown. Last updated 4 February 2021.

Last reviewed 2021-02-04 · How we verify

NCT04668911: ORACLE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oral Health, Microbial Burden and COVID-19

Status unknown Last updated 4 February 2021

What this trial tests

trial testing Swab in Covid19 in 150 participants. Status unknown.

Timeline

13 December 2020

Primary endpoint
12 December 2021

12 December 2021

Quick facts

Lead sponsor	Eastman Dental Insitute and Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	13 December 2020
Primary completion	12 December 2021
Estimated completion	12 December 2021
Sites	1 location across United Kingdom

Drugs / interventions tested

Swab

Conditions studied

Covid19 — all drugs for Covid19 →
Periodontitis — all drugs for Periodontitis →

Sponsor

Eastman Dental Insitute and Hospital

Who can join

18 and older, any sex, with Covid19 or Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An observational study of patients with COVID-19 confirmed cases (with various degrees of severity) and controls. Oral and nasal swabs will be taken from 150 patients (50 with mild form and 50 with severe form of COVID-19 with or without mechanical ventilation, 50 healthy controls).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Swab

Trials testing the same drug.

NCT04288921 — Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites · NA · unknown
NCT05267119 — Comparison of Scalp Microbiome of Healthy Women Wearing Hijab and Those Who do Not Wear Hijab · completed

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Eastman Dental Insitute and Hospital trials

Trials by the same sponsor.

NCT05964127 — Peri-implantitis and Systemic Inflammation · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04668911 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eastman Dental Insitute and Hospital
Last refreshed: 4 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04668911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing